SEC Form D private-offering filing

Kylix Bio, Inc.

Name: Kylix Bio, Inc. - new SEC Form D private-offering filing, Dover, DE
Published: 2026-01-26

A new SEC Form D private-offering notice from Dover, DE, a $12,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Kylix Bio, Inc. site↗ Verified via SEC Form D

Biotech company developing AAV gene therapy programs for rare neuromuscular diseases, aiming to fund first in human trials and exit at a de risked stage.

Filed 2026-01-26Filed to raise $12,000,000First money in 2026-01-15Raised so far $850,000HQ (as filed) Dover, DESector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified kylix.bio↗Named in the filing 3 executives & directors

Open this row on the live feed →More new filings in Delaware →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.